LTRN · Forms 3, 4, 5
Insider trades at Lantern Pharma Inc.
No open-market insider buys or sells at Lantern Pharma Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Lantern Pharma Inc. (LTRN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Lantern Pharma Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lee Troy Schalop | Director | Buy | 48,544 | $2.06 | $100K | Form 4 | |
| D Jeffrey Keyser | Director | Buy | 48,544 | $2.06 | $100K | Form 4 | |
| D Jeffrey Keyser | Director | Options or other derivatives | Form 4 | ||||
| Maria-Luisa Maccecchini | Director | Options or other derivatives | Form 4 | ||||
| Vijay Chandru | Director | Options or other derivatives | Form 4 | ||||
| Lee Troy Schalop | Director | Options or other derivatives | Form 4 | ||||
| David S. Silberstein | Director | Options or other derivatives | Form 4 | ||||
| David R. Margrave | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Kishor G. Bhatia | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Vijay Chandru | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.